Protocol No.: BPR-PIP-001

Title
An open-label study to evaluate the single-dose pharmacokinetics and safety of ceftobiprole in neonate and infant subjects aged up to 3 months undergoing treatment with systemic antibiotics
Principal Investigator
Polak, Mark
Phase
I
Age Group
Children
Applicable Disease Site
Neonatology
Participating Institution
Health Sciences Center
Contacts

View on ClinicalTrials.gov